IMp. D (PharMeuropa): 17-Hydroxy-3,11,20-Trioxopregn-4-en-21-yl Acetate(Cortisone Acetate)
|
|
IMp. D (PharMeuropa): 17-Hydroxy-3,11,20-Trioxopregn-4-en-21-yl Acetate(Cortisone Acetate) Eigenschaften
Sicherheit
IMp. D (PharMeuropa): 17-Hydroxy-3,11,20-Trioxopregn-4-en-21-yl Acetate(Cortisone Acetate) Chemische Eigenschaften,Einsatz,Produktion Methoden
IMp. D (PharMeuropa): 17-Hydroxy-3,11,20-Trioxopregn-4-en-21-yl Acetate(Cortisone Acetate) Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
IMp. D (PharMeuropa): 17-Hydroxy-3,11,20-Trioxopregn-4-en-21-yl Acetate(Cortisone Acetate) Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 1)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
S.Z. PhyStandard Bio-Tech. Co., Ltd. | 0755-83725681-603 |
China | 4496 | 50 |
- IMp. D (PharMeuropa): 17-Hydroxy-3,11,20-Trioxopregn-4-en-21-yl Acetate(Cortisone Acetate)